<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 17-year-old Japanese boy with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> was treated with oxymetholone and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> for 9 weeks without improvement </plain></SENT>
<SENT sid="1" pm="."><plain>He then received 2 courses of bolus methylprednisone therapy without improvement and developed a severe <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> due to this bolus therapy </plain></SENT>
<SENT sid="2" pm="."><plain>He had no HLA-compatible sibling for a bone marrow transplantation, and antithymus globulin was not available </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 7 lymphocytapheresis treatments were performed, using an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBM</z:e> 2997 cell separator, over a period of 9 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>Hematological and clinical improvement were noted and felt to be related with these lymphocytapheresis treatments, and further therapy was not required </plain></SENT>
<SENT sid="5" pm="."><plain>Three years have past since the patient has undergone lymphocytapheresis, and he remains in good health </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, lymphocytapheresis may be an alternative therapy for cases of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> for those patients who have no compatible donor for bone marrow transplantation and when antithymus globulin is not available </plain></SENT>
</text></document>